A prospective randomized open-label study of single injection vs continuous adductor canal block for postoperative analgesia after total knee arthroplasty
The Bone & Joint Journal Mar 15, 2019
Elkassabany NM, et al. - In this prospective, randomized, unblinded study, researchers examined 159 candidates to estimate the analgesic benefits and physiotherapy (PT) consequences of single-shot Adductor canal block (ACB) to 2 different regimens of infusion of the continuous ACB ie, 24-hour and 48-hour infusion. They recorded 21% of patients describing severe pain on postoperative day number 2 (POD 2) for the single-shot group, 14% for the 24-hour block group, whereas 12% for the 48-hour block group. They found no obvious benefit of the 24-hour or 48-hour infusions over the single-shot ACB for the primary endpoint of the study. All the candidates had comparable opioid usage, length of hospital stay, and functional outcomes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries